A detailed history of Somerville Kurt F transactions in Novo Nordisk A S stock. As of the latest transaction made, Somerville Kurt F holds 8,820 shares of NVO stock, worth $998,865. This represents 0.22% of its overall portfolio holdings.

Number of Shares
8,820
Previous 9,740 9.45%
Holding current value
$998,865
Previous $1.25 Million 0.64%
% of portfolio
0.22%
Previous 0.22%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$122.71 - $146.91 $112,893 - $135,157
-920 Reduced 9.45%
8,820 $1.26 Million
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $23,689 - $31,533
232 Added 2.44%
9,740 $1.25 Million
Q4 2023

Feb 13, 2024

SELL
$87.78 - $105.45 $70,224 - $84,360
-800 Reduced 7.76%
9,508 $983,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $467,158 - $1.03 Million
5,137 Added 99.34%
10,308 $937,000
Q2 2023

Aug 11, 2023

SELL
$155.98 - $172.65 $1.09 Million - $1.2 Million
-6,978 Reduced 57.44%
5,171 $836,000
Q1 2023

May 10, 2023

SELL
$132.34 - $159.14 $20,248 - $24,348
-153 Reduced 1.24%
12,149 $1.93 Million
Q4 2022

Feb 09, 2023

SELL
$102.55 - $135.33 $13,331 - $17,592
-130 Reduced 1.05%
12,302 $1.66 Million
Q3 2022

Nov 08, 2022

SELL
$95.28 - $116.93 $45,734 - $56,126
-480 Reduced 3.72%
12,432 $1.24 Million
Q2 2022

Jul 19, 2022

SELL
$103.24 - $121.81 $241,581 - $285,035
-2,340 Reduced 15.34%
12,912 $1.44 Million
Q1 2022

May 17, 2022

SELL
$93.1 - $112.54 $13,965 - $16,881
-150 Reduced 0.97%
15,252 $1.69 Million
Q4 2021

Feb 08, 2022

SELL
$95.88 - $117.08 $170,954 - $208,753
-1,783 Reduced 10.38%
15,402 $1.73 Million
Q3 2021

Nov 10, 2021

SELL
$84.42 - $106.62 $12,072 - $15,246
-143 Reduced 0.83%
17,185 $1.65 Million
Q2 2021

Aug 09, 2021

SELL
$67.66 - $84.76 $135 - $169
-2 Reduced 0.01%
17,328 $1.45 Million
Q2 2020

Jul 28, 2020

SELL
$58.54 - $67.94 $292 - $339
-5 Reduced 0.03%
17,330 $1.14 Million
Q1 2020

May 07, 2020

SELL
$49.46 - $64.78 $22,998 - $30,122
-465 Reduced 2.61%
17,335 $1.04 Million
Q3 2019

Nov 06, 2019

SELL
$47.54 - $53.43 $11,885 - $13,357
-250 Reduced 1.39%
17,800 $920,000
Q2 2019

Jul 24, 2019

SELL
$46.79 - $52.47 $93,580 - $104,940
-2,000 Reduced 9.98%
18,050 $921,000
Q1 2019

May 01, 2019

SELL
$46.36 - $52.63 $11,543 - $13,104
-249 Reduced 1.23%
20,050 $1.05 Million
Q3 2018

Oct 15, 2018

BUY
$46.76 - $51.24 $57,748 - $63,281
1,235 Added 6.48%
20,299 $957,000
Q2 2018

Jul 30, 2018

SELL
$44.29 - $50.42 $2,923 - $3,327
-66 Reduced 0.35%
19,064 $880,000
Q1 2018

Apr 24, 2018

SELL
$48.49 - $58.14 $48,490 - $58,140
-1,000 Reduced 4.97%
19,130 $943,000
Q4 2017

Feb 02, 2018

SELL
$47.53 - $53.73 $262,603 - $296,858
-5,525 Reduced 21.54%
20,130 $1.08 Million
Q3 2017

Oct 26, 2017

BUY
$41.15 - $49.22 $1.06 Million - $1.26 Million
25,655
25,655 $1.24 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $256B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Somerville Kurt F Portfolio

Follow Somerville Kurt F and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Somerville Kurt F, based on Form 13F filings with the SEC.

News

Stay updated on Somerville Kurt F with notifications on news.